fusidic acid has been researched along with Soft Tissue Infections in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Adam, HJ; Baxter, M; Karlowsky, JA; Lagace-Wiens, PRS; Zhanel, GG | 1 |
| Gómez-Recuero-Muñoz, L; Lozano-Masdemont, B; Pulido-Pérez, A | 1 |
| Cohen, R; Gillet, Y; Moulin, F; Quinet, B; Raymond, J | 1 |
| Castanheira, M; Jones, RN; Pfaller, MA; Sader, HS | 1 |
| Geng, W; Li, X; Liu, Y; Shang, Y; Shen, X; Wang, C; Wang, L; Wu, D; Yang, Y; Yao, K; Yu, S; Zheng, Y | 1 |
| Afset, JE; Maeland, JA | 1 |
| Henriksen, AS; Jarlier, V; Larsen, AR; Skov, RL | 1 |
| Spelman, D | 1 |
| Bismuth, R; Casin, I; Cavallo, JD; Croizé, J; Felten, A; Goldstein, F; Leclercq, R; Monteil, H; Quentin-Noury, C; Reverdy, M; Roiron, R; Vergnaud, M | 1 |
2 review(s) available for fusidic acid and Soft Tissue Infections
| Article | Year |
|---|---|
Staphylococcus lugdunensis: An Emerging Pathogen in Skin and Soft Tissue Infections.
Topics: Abscess; Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Communicable Diseases, Emerging; Female; Foot Diseases; Fusidic Acid; Humans; Insect Bites and Stings; Male; Middle Aged; Mupirocin; Soft Tissue Infections; Staphylococcal Skin Infections; Staphylococcus lugdunensis; Wound Infection | 2015 |
Fusidic acid in skin and soft tissue infections.
Topics: Administration, Oral; Administration, Topical; Anti-Bacterial Agents; Clinical Trials as Topic; Fusidic Acid; Humans; Skin Diseases, Bacterial; Skin Diseases, Infectious; Soft Tissue Infections; Staphylococcal Skin Infections; Streptococcal Infections; Streptococcus pyogenes | 1999 |
7 other study(ies) available for fusidic acid and Soft Tissue Infections
| Article | Year |
|---|---|
In vitro activity and resistance rates of topical antimicrobials fusidic acid, mupirocin and ozenoxacin against skin and soft tissue infection pathogens obtained across Canada (CANWARD 2007-18).
Topics: Aminopyridines; Anti-Bacterial Agents; Canada; Fusidic Acid; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mupirocin; Quinolones; Soft Tissue Infections; Staphylococcal Infections; Staphylococcus aureus | 2021 |
[Managing children skin and soft tissue infections].
Topics: Administration, Oral; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cellulitis; Cephalosporins; Child; Drug Resistance, Bacterial; Fasciitis, Necrotizing; Furunculosis; Fusidic Acid; Humans; Impetigo; Injections, Intravenous; Macrolides; Methicillin-Resistant Staphylococcus aureus; Mupirocin; Penicillins; Pristinamycin; Skin Diseases, Bacterial; Soft Tissue Infections; Staphylococcal Scalded Skin Syndrome; Staphylococcal Skin Infections; Staphylococcus aureus; Stevens-Johnson Syndrome; Streptococcal Infections; Streptococcus pyogenes | 2008 |
Evaluation of the activity of fusidic acid tested against contemporary Gram-positive clinical isolates from the USA and Canada.
Topics: Anti-Bacterial Agents; Bacteremia; Canada; Community-Acquired Infections; Cross Infection; Fusidic Acid; Humans; Microbial Sensitivity Tests; Soft Tissue Infections; Staphylococcal Infections; Staphylococcal Skin Infections; Staphylococcus; United States | 2010 |
Susceptibility to and resistance determinants of fusidic acid in Staphylococcus aureus isolated from Chinese children with skin and soft tissue infections.
Topics: Adolescent; Anti-Bacterial Agents; Bacterial Proteins; Child; Child, Preschool; China; Drug Resistance, Bacterial; Fusidic Acid; Humans; Infant; Microbial Sensitivity Tests; Soft Tissue Infections; Staphylococcal Skin Infections; Staphylococcus aureus | 2012 |
Susceptibility of skin and soft-tissue isolates of Staphylococcus aureus and Streptococcus pyogenes to topical antibiotics: indications of clonal spread of fusidic acid-resistant Staphylococcus aureus.
Topics: Administration, Topical; Adolescent; Adult; Anti-Bacterial Agents; Bacitracin; Child; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Fusidic Acid; Genes, Bacterial; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mupirocin; Probability; Sensitivity and Specificity; Skin Diseases, Bacterial; Soft Tissue Infections; Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections; Streptococcus pyogenes | 2003 |
Epidemiological differences between the UK and Ireland versus France in Staphylococcus aureus isolates resistant to fusidic acid from community-acquired skin and soft tissue infections.
Topics: Community-Acquired Infections; Drug Resistance, Bacterial; France; Fusidic Acid; Humans; Ireland; Soft Tissue Infections; Staphylococcal Skin Infections; Staphylococcus aureus; United Kingdom | 2008 |
In vitro activity of fusidic acid against streptococci isolated from skin and soft tissue infections.
Topics: Anti-Bacterial Agents; Fusidic Acid; Humans; Microbial Sensitivity Tests; Skin; Skin Diseases, Bacterial; Soft Tissue Infections; Streptococcal Infections; Streptococcus | 2000 |